(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
Sponsor: National Cancer Institute (NCI)
A observational or N/A phase clinical study on Brain Cancer and Brain Neoplasms, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 17 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
May 2019 — Jan 2021 [monthly]
Completed
-
Apr 2019 — May 2019 [monthly]
Completed
▶ Show 12 earlier versions
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Jan 2019 — Mar 2019 [monthly]
Completed
-
Nov 2018 — Jan 2019 [monthly]
Completed
-
Oct 2018 — Nov 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .